A Phase 1/2 Study of Picoplatin and Docetaxel (With Prednisone) in Subjects With Chemotherapy-Naive Metastatic Hormone-Refractory Prostate Cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Picoplatin (Primary) ; Docetaxel; Prednisolone; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 05 Mar 2010 Final results presented at ASCO Genitourinary Cancers Symposium 2010.
- 05 Mar 2010 Status changed from active, no longer recruiting to completed based on presentation of final results.
- 25 Feb 2009 Results will be presented at the American Society of Clinical Oncology's 2009 Genitourinary Cancers Symposium, in a poster session (abstract 186) on Feb 27.